Page last updated: 2024-09-03

cgp 28392 and oxadiazoles

cgp 28392 has been researched along with oxadiazoles in 4 studies

Compound Research Comparison

Studies
(cgp 28392)
Trials
(cgp 28392)
Recent Studies (post-2010)
(cgp 28392)
Studies
(oxadiazoles)
Trials
(oxadiazoles)
Recent Studies (post-2010) (oxadiazoles)
76126,0572572,359

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bolger, GT; Campbell, N; Crowley, M; McKay, DW; O'Neill, SK; Triggle, CR1
Fraser, S; Kenny, BA; Kilpatrick, AT; Spedding, M1
Carpenter, CL; Greenberg, DA; Messing, RO1
Barhanin, J; Borsotto, M; Fosset, M; Galizzi, JP; Lazdunski, M; Renaud, JF; Romey, G; Schmid, A1

Other Studies

4 other study(ies) available for cgp 28392 and oxadiazoles

ArticleYear
Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 253, Issue:3

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Brain; Calcium Channel Agonists; Catecholamines; Chromatography, High Pressure Liquid; Dihydropyridines; Guinea Pigs; Injections, Intraperitoneal; Male; Mice; Motor Activity; Muscle Contraction; Muscle, Smooth; Nicotinic Acids; Nifedipine; Oxadiazoles; Pyridines; Stereoisomerism; Structure-Activity Relationship

1990
Selective antagonism of calcium channel activators by fluspirilene.
    British journal of pharmacology, 1990, Volume: 100, Issue:2

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Binding Sites; Binding, Competitive; Calcium Channel Agonists; Calcium Channel Blockers; Cecum; Cerebral Cortex; Female; Fluspirilene; Guinea Pigs; In Vitro Techniques; Isradipine; Kinetics; Muscle, Smooth; Oxadiazoles; Potassium; Pyridines; Radioligand Assay; Spiro Compounds

1990
Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
    The Journal of pharmacology and experimental therapeutics, 1986, Volume: 238, Issue:3

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Blockers; Cells, Cultured; Isradipine; Kinetics; Membrane Potentials; Nifedipine; Nitrendipine; Onium Compounds; Organophosphorus Compounds; Oxadiazoles; Potassium; Pyridines; Tritium

1986
Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Journal of cardiovascular pharmacology, 1986, Volume: 8 Suppl 8

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Affinity Labels; Animals; Bepridil; Binding, Competitive; Calcium; Calcium Channel Blockers; Calcium Channels; Chick Embryo; Cholic Acids; Diltiazem; Ion Channels; Isradipine; Kinetics; Macromolecular Substances; Molecular Weight; Muscles; Myocardial Contraction; Oxadiazoles; Pyridines; Pyrrolidines; Receptors, Nicotinic; Verapamil

1986